197 related articles for article (PubMed ID: 31399069)
1. Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data.
Sinnecker T; Hadisurya J; Schneider-Hohendorf T; Schwab N; Wrede K; Gembruch O; Gold R; Hellwig K; Pilgram-Pastor S; Adams O; Albrecht P; Hartung HP; Aktas O; Kraemer M
BMC Neurol; 2019 Aug; 19(1):190. PubMed ID: 31399069
[TBL] [Abstract][Full Text] [Related]
2. Progressive multifocal leukoencephalopathy or immune reconstitution inflammatory syndrome after fingolimod cessation? A case report.
Mickeviciene D; Baltusiene A; Afanasjeva B; Afanasjevas D; Gleizniene R; Rastenyte D; Berger JR
BMC Neurol; 2022 Aug; 22(1):306. PubMed ID: 35986243
[TBL] [Abstract][Full Text] [Related]
3. Three cases of non-carryover fingolimod-PML: Is the risk in Japan increased?
Nakahara J; Tomaske L; Kume K; Takata T; Kamada M; Deguchi K; Kufukihara K; Schneider R; Gold R; Ayzenberg I
Neurol Neuroimmunol Neuroinflamm; 2019 May; 6(3):e559. PubMed ID: 31044147
[TBL] [Abstract][Full Text] [Related]
4. Management approach including pembrolizumab for fingolimod-associated progressive multifocal leukoencephalopathy in a patient with relapsing-remitting multiple sclerosis.
Barritt AW; Das E; Morley N; Seymour M; Saha R; Vera J; Vundavalli S; Dizdarevic S; Nicholas R; Berger JR; Fisniku LK
Mult Scler; 2023 Feb; 29(2):301-306. PubMed ID: 36451581
[TBL] [Abstract][Full Text] [Related]
5. Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases.
N'gbo N'gbo Ikazabo R; Mostosi C; Quivron B; Delberghe X; El Hafsi K; Lysandropoulos AP
Clin Ther; 2016 Mar; 38(3):670-5. PubMed ID: 26856928
[TBL] [Abstract][Full Text] [Related]
6. Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML.
Fischer-Barnicol B; Oechtering J; Kuhle J; Lorscheider J; Kappos L; Derfuss T
Neurol Neuroimmunol Neuroinflamm; 2021 Jan; 8(1):. PubMed ID: 33272956
[No Abstract] [Full Text] [Related]
7. The utility of FDG-PET imaging in distinguishing PML-IRIS from PML in a patient treated with natalizumab.
Baheerathan A; McNamara C; Kalam S; Rane N; Barwick TD; Grote H; Nicholas R
Neurology; 2018 Sep; 91(12):572-573. PubMed ID: 30224501
[No Abstract] [Full Text] [Related]
8. Fingolimod-associated PML in a patient with prior immunosuppression.
Gyang TV; Hamel J; Goodman AD; Gross RA; Samkoff L
Neurology; 2016 May; 86(19):1843-5. PubMed ID: 27164718
[No Abstract] [Full Text] [Related]
9. MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.
Wattjes MP; Wijburg MT; Vennegoor A; Witte BI; de Vos M; Richert ND; Uitdehaag BM; Barkhof F; Killestein J;
J Neurol Neurosurg Psychiatry; 2016 Aug; 87(8):879-84. PubMed ID: 26369555
[TBL] [Abstract][Full Text] [Related]
10. Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab.
Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ
J Clin Neurosci; 2015 Mar; 22(3):598-600. PubMed ID: 25523125
[TBL] [Abstract][Full Text] [Related]
11. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory natalizumab-associated PML: baseline characteristics, lesion evolution and relation with PML-IRIS.
Wattjes MP; Wijburg MT; van Eijk J; Frequin S; Uitdehaag BMJ; Barkhof F; Warnke C; Killestein J;
J Neurol Neurosurg Psychiatry; 2018 May; 89(5):535-541. PubMed ID: 29142146
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy - immune reconstitution inflammatory syndrome (PML-IRIS) in liver transplant recipient.
Avsenik J; Horvat Ledinek A; Šurlan Popovič K
Mult Scler Relat Disord; 2017 Oct; 17():135-137. PubMed ID: 29055444
[TBL] [Abstract][Full Text] [Related]
14. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
[TBL] [Abstract][Full Text] [Related]
15. Extensive white matter lesions after 2 years of fingolimod: Progressive multifocal leukoencephalopathy or MS relapse?
Boudot de la Motte M; Louapre C; Bertrand A; Reach P; Lubetzki C; Papeix C; Maillart E
Mult Scler; 2017 Apr; 23(4):614-616. PubMed ID: 28273764
[TBL] [Abstract][Full Text] [Related]
16. Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
Maillart E; Louapre C; Lubetzki C; Papeix C
Mult Scler; 2014 Apr; 20(4):505-9. PubMed ID: 24367037
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.
Gheuens S; Smith DR; Wang X; Alsop DC; Lenkinski RE; Koralnik IJ
Neurology; 2012 May; 78(18):1390-3. PubMed ID: 22517104
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS.
Marousi S; Travasarou M; Karageorgiou CE; Gheuens S; Koralnik IJ
Neurology; 2012 Nov; 79(21):2160; author reply 2160. PubMed ID: 23170016
[No Abstract] [Full Text] [Related]
19. Progressive Multifocal Leukoencephalopathy in the Absence of Typical Radiological Changes: Can We Make a Diagnosis?
AlTahan AM; Berger T; AlOrainy IA; AlTahan H
Am J Case Rep; 2019 Jan; 20():101-105. PubMed ID: 30674865
[TBL] [Abstract][Full Text] [Related]
20. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F
Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
